Novel findings with dual SGLT1 and SGLT2 inhibitor in diabetes patients
This video was recorded during the virtual congress of the AHA Scientific Sessions 2020.
Deepak Bhatt, MD, is executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, Boston, MA, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: